mesalamine and ono4819

mesalamine has been researched along with ono4819 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiba, T; Esaki, Y; Fujiyama, Y; Matsuoka, T; Murayama, T; Nakase, H; Narumiya, S; Nonomura, K; Oga, T; Oshitani, N; Teramukai, S	1

Trials

1 trial(s) available for mesalamine and ono4819

Article	Year
Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial. Inflammatory bowel diseases, 2010, Volume: 16, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Drug Resistance; Female; Heptanoates; Humans; Male; Mesalamine; Middle Aged; Placebos; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Treatment Outcome	2010

Article

Year

Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial.

Inflammatory bowel diseases, 2010, Volume: 16, Issue:5

Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Drug Resistance; Female; Heptanoates; Humans; Male; Mesalamine; Middle Aged; Placebos; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Treatment Outcome

2010